ZA98978B - Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/ stress protein-peptide complexes - Google Patents
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/ stress protein-peptide complexesInfo
- Publication number
- ZA98978B ZA98978B ZA98978A ZA98978A ZA98978B ZA 98978 B ZA98978 B ZA 98978B ZA 98978 A ZA98978 A ZA 98978A ZA 98978 A ZA98978 A ZA 98978A ZA 98978 B ZA98978 B ZA 98978B
- Authority
- ZA
- South Africa
- Prior art keywords
- prevention
- primary
- treatment
- diseases
- heat shock
- Prior art date
Links
- 208000035473 Communicable disease Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001394 metastastic effect Effects 0.000 title 1
- 206010061289 metastatic neoplasm Diseases 0.000 title 1
- 230000001613 neoplastic effect Effects 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000035939 shock Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4614—Monocytes; Macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/464476—Heat shock proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6043—Heat shock proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/622—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier non-covalent binding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/53—Liver
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/796,319 US6017540A (en) | 1997-02-07 | 1997-02-07 | Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA98978B true ZA98978B (en) | 1998-08-17 |
Family
ID=25167905
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA98978A ZA98978B (en) | 1997-02-07 | 1998-02-06 | Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/ stress protein-peptide complexes |
Country Status (7)
Country | Link |
---|---|
US (16) | US6017540A (fr) |
EP (1) | EP0973548A4 (fr) |
JP (1) | JP2001511785A (fr) |
AU (1) | AU724772B2 (fr) |
CA (1) | CA2281699A1 (fr) |
WO (1) | WO1998034641A1 (fr) |
ZA (1) | ZA98978B (fr) |
Families Citing this family (122)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5997873A (en) | 1994-01-13 | 1999-12-07 | Mount Sinai School Of Medicine Of The City University Of New York | Method of preparation of heat shock protein 70-peptide complexes |
US6773707B1 (en) * | 1995-08-18 | 2004-08-10 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
US6719974B1 (en) * | 1995-08-18 | 2004-04-13 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
US6663868B1 (en) * | 1995-08-18 | 2003-12-16 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
US6761892B1 (en) * | 1995-08-18 | 2004-07-13 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
US5837251A (en) * | 1995-09-13 | 1998-11-17 | Fordham University | Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases |
US5985270A (en) * | 1995-09-13 | 1999-11-16 | Fordham University | Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes |
IN183280B (fr) | 1996-09-20 | 1999-10-30 | Univ New Mexico | |
US7157089B1 (en) | 1996-11-26 | 2007-01-02 | Stressgen Biotechnologies Corporation | Immune responses using compositions containing stress proteins |
US6017540A (en) | 1997-02-07 | 2000-01-25 | Fordham University | Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
US6709672B2 (en) * | 1997-03-05 | 2004-03-23 | Biotech Tools S.A. | Pharmaceutical or food composition for treating pathologies associated with graft rejection or an allergic or autoimmune reaction |
BE1011033A6 (fr) * | 1997-03-05 | 1999-04-06 | Univ Bruxelles | Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer. |
IL134341A0 (en) * | 1997-08-05 | 2001-04-30 | Stressgen Biotechnologies Corp | Compositions for inducing an immune response containing an hpv protein antigen |
IL135860A0 (en) * | 1997-10-31 | 2001-05-20 | Sloan Kettering Inst Cancer | Conjugate heat shock protein-binding peptides |
US5948646A (en) | 1997-12-11 | 1999-09-07 | Fordham University | Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes |
EP2295065B1 (fr) * | 1998-02-20 | 2013-10-09 | The University of Miami | Complexe de peptide antigènes à protéines de choc thermique modifiées |
US20030236209A1 (en) * | 1998-03-18 | 2003-12-25 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
US7579160B2 (en) * | 1998-03-18 | 2009-08-25 | Corixa Corporation | Methods for the detection of cervical cancer |
WO2000014547A1 (fr) * | 1998-09-04 | 2000-03-16 | Powderject Research Limited | Immunodiagnostics au moyen de procedes d'administration de particules |
US20020142974A1 (en) * | 1998-09-11 | 2002-10-03 | Leonard D. Kohn | Immune activation by double-stranded polynucleotides |
JP2003504074A (ja) * | 1999-07-08 | 2003-02-04 | ストレスゲン バイオテクノロジーズ コーポレイション | インビトロでのTh1様応答の誘導 |
AUPQ233799A0 (en) | 1999-08-19 | 1999-09-09 | Minister For Agriculture, Minister For Land And Water Conservation For And On Behalf Of The State Of New South Wales | Recombinant sub-unit vaccine |
GB9919733D0 (en) * | 1999-08-19 | 1999-10-20 | Colaco Camilo | Vaccines against intracellular pathogens |
US7378096B2 (en) | 1999-09-30 | 2008-05-27 | Health Research, Inc. | Stress protein compositions and methods for prevention and treatment of cancer and infectious disease |
WO2001023421A2 (fr) * | 1999-09-30 | 2001-04-05 | Corixa Corporation | Compositions des proteines du stress et procedes de prevention et de traitement d'un cancer et d'une maladie infectieuse |
US8128922B2 (en) | 1999-10-20 | 2012-03-06 | Johns Hopkins University | Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen |
AU1582801A (en) * | 1999-11-05 | 2001-06-06 | Board Of Regents Of The University Of Nebraska, The | Methods and compositions for protection against bovine herpesvirus |
US7030228B1 (en) | 1999-11-15 | 2006-04-18 | Miltenyi Biotec Gmbh | Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
GB9930443D0 (en) | 1999-12-22 | 2000-02-16 | King S College London | Novel use of heat shock proteins |
US20010034042A1 (en) * | 2000-01-20 | 2001-10-25 | Srivastava Pramod K. | Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents |
US7297330B2 (en) * | 2000-02-04 | 2007-11-20 | Thomas Jefferson University | Low dose haptenized tumor cell and tumor cell extract immunotherapy |
DE10019967A1 (de) * | 2000-04-20 | 2001-10-25 | Fenning Biomed Gmbh Dr | Antikörper gegen natives gp96, deren Herstellung und Verwendung |
JP2004505894A (ja) | 2000-06-02 | 2004-02-26 | ユニバーシティー オブ コネティカット ヘルス センター | 免疫療法のためのα(2)マクログロブリンと抗原分子との複合体 |
US7179462B2 (en) | 2000-06-02 | 2007-02-20 | University Of Connecticut Health Center | α (2) macroglobulin receptor as a heat shock protein receptor and uses thereof |
US7186515B1 (en) | 2000-06-02 | 2007-03-06 | University Of Connecticut Health Center | Alpha(2) macroglobulin receptor as a heat shock protein receptor and uses thereof |
IL153474A0 (en) | 2000-06-26 | 2003-07-06 | Stressgen Biotechnologies Corp | Human papilloma virus treatment |
JP5087201B2 (ja) * | 2000-08-03 | 2012-12-05 | ジョンズ・ホプキンス・ユニバーシティ | 抗原に小胞体シャペロンポリペプチドを連結した分子ワクチン |
CN1107681C (zh) * | 2000-08-11 | 2003-05-07 | 中国科学院微生物研究所 | 乙肝病毒抗原多肽与热休克蛋白的复合物及其应用 |
CA2422867A1 (fr) * | 2000-09-15 | 2002-04-25 | University Of Connecticut Health Center | Formulations ameliorees utilisant des complexes peptides-proteines de choc thermique/de stress |
US20020172682A1 (en) * | 2000-10-20 | 2002-11-21 | University Of Connecticut Health Center | Using heat shock proteins to increase immune response |
US7132109B1 (en) | 2000-10-20 | 2006-11-07 | University Of Connecticut Health Center | Using heat shock proteins to increase immune response |
PL373675A1 (en) * | 2001-02-05 | 2005-09-05 | Stressgen Biotechnologies Corporation | Hepatitis b virus treatment |
JP2004532252A (ja) * | 2001-05-31 | 2004-10-21 | スカイファーマ インコーポレーテッド | リポソームおよびミクロスフェア中のナノ懸濁物のカプセル化 |
US7094754B2 (en) | 2001-08-16 | 2006-08-22 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7186693B2 (en) | 2001-08-16 | 2007-03-06 | Kimberly - Clark Worldwide, Inc. | Metalloproteinase inhibitors for wound healing |
US6906036B2 (en) | 2001-08-16 | 2005-06-14 | Kimberly-Clark Worldwide, Inc. | Anti-aging and wound healing compounds |
US7071164B2 (en) | 2001-08-16 | 2006-07-04 | Kimberly-Clark Worldwide, Inc. | Anti-cancer and wound healing compounds |
EP1536829A4 (fr) * | 2001-08-20 | 2006-05-31 | Univ Connecticut Health Ct | Procedes de preparation de compositions a base de proteines du stress ou de alpha-2-macroglobuline utilisees dans le traitement du cancer et des maladies infectieuses |
US20030211971A1 (en) * | 2001-09-17 | 2003-11-13 | Srivastava Pramod K. | Compositions and methods for prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with compositions comprising unfractionated cellular proteins |
JP2005512519A (ja) | 2001-10-01 | 2005-05-12 | デューク・ユニバーシティ | 単離grp94リガンド結合ドメインポリペプチドおよびそれをコードする核酸、その結晶、およびそれを用いるスクリーニング方法 |
US20030194409A1 (en) * | 2002-01-17 | 2003-10-16 | Rothman James E. | Conjugate heat shock protein-binding peptides |
JP2005530487A (ja) * | 2002-02-28 | 2005-10-13 | アンティジェニクス インコーポレーテッド | ストレスタンパク質のオリゴマー化に基づく方法および生成物 |
CA2483449A1 (fr) | 2002-04-25 | 2003-11-06 | University Of Connecticut Health Center | Utilisation de proteines de choc thermique pour ameliorer l'avantage therapeutique d'une modalite de traitement non vaccinal |
US6984389B2 (en) | 2002-04-25 | 2006-01-10 | University Of Connecticut Health Center | Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
RU2375077C2 (ru) * | 2002-05-02 | 2009-12-10 | Юниверсити Оф Коннектикут Хелт Сентер | Использование белков теплового шока для повышения эффективности терапий антителами |
ATE474851T1 (de) * | 2002-10-02 | 2010-08-15 | Hoffmann La Roche | Verfahren zur identifizierung antigener peptide |
EP1576124A2 (fr) * | 2002-10-07 | 2005-09-21 | Antigenics Inc. | Fragments de cd91 de liaison a des proteines de choc thermique et utilisations de ceux-ci |
JP2006512942A (ja) * | 2002-10-25 | 2006-04-20 | ユニバーシティー オブ コネティカット ヘルス センター | 制御細胞溶解による癌の免疫療法のための装置と方法 |
AU2003302986A1 (en) | 2002-12-13 | 2004-07-09 | Aurelium Biopharma Inc. | Nucleophosmin directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
US7550256B2 (en) * | 2002-12-13 | 2009-06-23 | Aurelium Biopharma, Inc. | Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
US7670604B2 (en) | 2002-12-13 | 2010-03-02 | Aurelium Biopharma, Inc. | Vimentin directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
US7148194B2 (en) | 2002-12-30 | 2006-12-12 | Kimberly-Clark Worldwide, Inc. | Method to increase fibronectin |
AU2003300676A1 (en) * | 2003-01-03 | 2004-07-29 | Aurelium Biopharma Inc. | Hsc70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease |
WO2004066947A2 (fr) * | 2003-01-28 | 2004-08-12 | Shanghai Sunway Biotech Co., Ltd. | Traitement pour cancers primaires et metastatiques |
US7420037B2 (en) | 2003-02-13 | 2008-09-02 | Antigenics Inc. | Heat shock protein-based vaccines and immunotherapies |
CA2514500A1 (fr) * | 2003-02-20 | 2004-09-10 | University Of Connecticut Health Center | Methodes d'utilisation de compositions contenant des proteines du stress ou une macroglobuline alpha-2 dans le traitement de cancer et de maladie infectieuse |
US7638122B2 (en) * | 2003-03-07 | 2009-12-29 | University Of South Florida | Stat3 antagonists and their use as vaccines against cancer |
WO2004080819A2 (fr) * | 2003-03-14 | 2004-09-23 | Aurelium Biopharma Inc. | Methode de diagnostic et de therapie ciblant la triose-phosphate isomerase, destinee aux maladies neoplasiques a multiresistance aux medicaments |
US7309491B2 (en) * | 2003-04-11 | 2007-12-18 | Antigenics Inc. | Heat shock protein-based vaccines and immunotherapies |
EP1644048B1 (fr) * | 2003-05-05 | 2015-04-29 | Johns Hopkins University | Vaccin a adn anti-cancer faisant appel a des plasmides codant une sequence-signal, un antigene oncoproteine mutant, et une proteine de choc thermique |
JP2007504840A (ja) * | 2003-05-12 | 2007-03-08 | ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア | Grp94ベース組成物及びそれらの使用方法 |
US20060029610A1 (en) * | 2003-05-12 | 2006-02-09 | Yair Argon | GRP94-based compositions and methods of use thereof |
US7189700B2 (en) | 2003-06-20 | 2007-03-13 | Kimberly-Clark Worldwide, Inc. | Anti-chrondrosarcoma compounds |
EP1801202A4 (fr) * | 2004-09-03 | 2008-02-06 | Medical & Biol Lab Co Ltd | Processus pour produire une cellule dendritique ayant acquis une capacité d'induction du ctl |
JPWO2006025525A1 (ja) * | 2004-09-03 | 2008-05-08 | 株式会社医学生物学研究所 | 樹状細胞において抗原提示されやすいタンパク質の選択方法 |
WO2006073970A2 (fr) * | 2005-01-06 | 2006-07-13 | The Johns Hopkins University | Interference arn bloquant l'expression de l'immunite potentialisee de proteines pro-apoptotiques induite par adn et des vaccins de cellules dendritiques transfectes |
EP1846026A4 (fr) * | 2005-01-26 | 2008-07-02 | Univ Johns Hopkins | Vaccin d'adn anticancereux utilisant des plasmides codant un antigene et une calreticuline tels que des oncoproteines mutantes |
US20070167422A1 (en) * | 2006-01-18 | 2007-07-19 | Yu Kwok S | Pharmaceutical compositions comprising 17-allylamino-17-demethoxygeldanamycin |
WO2008024844A2 (fr) * | 2006-08-22 | 2008-02-28 | The Johns Hopkins University | Combinaisons thérapeutiques anticancers |
EP2360182A1 (fr) * | 2006-11-13 | 2011-08-24 | Functional Genetics, Inc. | Ciblage thérapeutique de protéines d'escorte |
US9085638B2 (en) | 2007-03-07 | 2015-07-21 | The Johns Hopkins University | DNA vaccine enhancement with MHC class II activators |
US20080260765A1 (en) * | 2007-03-15 | 2008-10-23 | Johns Hopkins University | HPV DNA Vaccines and Methods of Use Thereof |
JP2011513399A (ja) | 2008-03-03 | 2011-04-28 | ザ ユニバーシティー オブ マイアミ | 同種癌細胞による免疫療法 |
WO2009117116A2 (fr) | 2008-03-20 | 2009-09-24 | University Of Miami | Vaccination par protéine de choc thermique gp96 et procédés d'utilisation |
US20090285861A1 (en) * | 2008-04-17 | 2009-11-19 | Tzyy-Choou Wu | Tumor cell-based cancer immunotherapeutic compositions and methods |
US7932018B2 (en) * | 2008-05-06 | 2011-04-26 | Az Electronic Materials Usa Corp. | Antireflective coating composition |
ES2963910T3 (es) | 2008-06-26 | 2024-04-03 | Zevra Denmark As | Uso de Hsp70 como regulador de la actividad enzimática |
GB0816242D0 (en) * | 2008-09-05 | 2008-10-15 | Immunobiology Ltd | Method of purifying protien complexes |
US9782565B2 (en) | 2008-10-01 | 2017-10-10 | Covidien Lp | Endoscopic ultrasound-guided biliary access system |
US8968210B2 (en) | 2008-10-01 | 2015-03-03 | Covidien LLP | Device for needle biopsy with integrated needle protection |
US9332973B2 (en) | 2008-10-01 | 2016-05-10 | Covidien Lp | Needle biopsy device with exchangeable needle and integrated needle protection |
US9186128B2 (en) | 2008-10-01 | 2015-11-17 | Covidien Lp | Needle biopsy device |
US11298113B2 (en) | 2008-10-01 | 2022-04-12 | Covidien Lp | Device for needle biopsy with integrated needle protection |
WO2010060026A1 (fr) * | 2008-11-21 | 2010-05-27 | University Of Miami | Vaccins contre vih/vis pour la génération d’immunité muqueuse et systémique |
GB0910591D0 (en) | 2009-06-19 | 2009-07-29 | Immunobiology Ltd | Method for the purification of protein complexes |
EP2646044B1 (fr) | 2010-11-30 | 2019-08-28 | Orphazyme A/S | Procédés pour accroître l'activité cellulaire de hsp70 |
FR3005649B1 (fr) | 2013-05-15 | 2023-03-31 | Urodelia | Poudre d'hydroxyapatite et son procede de production, composition a base de cette poudre et son procede de preparation et kit comprenant cette poudre |
PT3148579T (pt) | 2014-05-28 | 2021-03-11 | Ludwig Inst For Cancer Res Ltd | Anticorpos anti-gitr e métodos da sua utilização |
AU2015317447B2 (en) | 2014-09-15 | 2021-02-25 | Zevra Denmark A/S | Arimoclomol formulation |
MX2017010159A (es) | 2015-02-06 | 2017-12-18 | Heat Biologics Inc | Vector que expresa conjuntamente vacunas y moléculas coestimuladoras. |
US10568948B2 (en) | 2015-05-13 | 2020-02-25 | Agenus Inc. | Vaccines for treatment and prevention of cancer |
EP3303394B1 (fr) | 2015-05-29 | 2020-04-08 | Agenus Inc. | Anticorps anti-ctla-4 et méthodes d'utilisation de ceux-ci |
EA201890630A1 (ru) | 2015-09-01 | 2018-10-31 | Эйдженус Инк. | Антитела против pd-1 и способы их применения |
US11447557B2 (en) | 2015-12-02 | 2022-09-20 | Agenus Inc. | Antibodies and methods of use thereof |
US10898563B2 (en) * | 2016-02-29 | 2021-01-26 | The Curators Of The University Of Missouri | Cancer immune-based therapy |
US10898476B2 (en) | 2016-04-13 | 2021-01-26 | Orphazyme A/S | Heat shock proteins and cholesterol homeostasis |
HUE052158T2 (hu) | 2016-04-29 | 2021-04-28 | Orphazyme As | Arimoklomol a glükocerebroszidázzal társult rendellenességek kezeléséhez |
SG11201810023QA (en) | 2016-05-27 | 2018-12-28 | Agenus Inc | Anti-tim-3 antibodies and methods of use thereof |
CA3040123A1 (fr) | 2016-10-11 | 2018-04-19 | University Of Miami | Vecteurs et cellules de vaccin pour immunite contre le virus zika |
KR20230133934A (ko) | 2016-10-11 | 2023-09-19 | 아게누스 인코포레이티드 | 항-lag-3 항체 및 이의 사용 방법 |
AU2017373944B2 (en) | 2016-12-07 | 2022-02-03 | Agenus Inc. | Anti-CTLA-4 antibodies and methods of use thereof |
CN110300599A (zh) | 2016-12-07 | 2019-10-01 | 艾吉纳斯公司 | 抗体和其使用方法 |
JP2020503883A (ja) | 2017-01-13 | 2020-02-06 | アジェナス インコーポレイテッド | Ny−eso−1に結合するt細胞受容体およびその使用方法 |
WO2018187260A1 (fr) | 2017-04-04 | 2018-10-11 | Heat Biologics, Inc. | Vaccination intratumorale |
MX2019012223A (es) | 2017-04-13 | 2019-12-09 | Agenus Inc | Anticuerpos anti-cd137 y metodos de uso de los mismos. |
EP3618863B1 (fr) | 2017-05-01 | 2023-07-26 | Agenus Inc. | Anticorps anti-tigit et leurs utilisations |
CA3073055A1 (fr) | 2017-09-04 | 2019-03-07 | Agenus Inc. | Recepteurs de lymphocytes t qui se lient a des phosphopeptides specifiques de la leucemie de lignee mixte (mll) et methodes d'utilisation de ces derniers |
FR3078887B1 (fr) | 2018-03-14 | 2020-12-18 | Urodelia | Vaccins autologues contre le cancer |
MA52363A (fr) | 2018-04-26 | 2021-03-03 | Agenus Inc | Compositions peptidiques de liaison à une protéine de choc thermique (hsp) et leurs méthodes d'utilisation |
KR20220053007A (ko) | 2019-08-30 | 2022-04-28 | 아게누스 인코포레이티드 | 항-cd96 항체 및 이의 사용 방법 |
US20230321276A1 (en) * | 2020-09-30 | 2023-10-12 | Alma Bio Therapeutics | Nucleic acid therapy for differential modulation of host microflora |
JP2024500632A (ja) | 2020-11-19 | 2024-01-10 | ゼブラ デンマーク エー/エス | アリモクロモルクエン酸塩及びその中間体の調製プロセス |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4690915A (en) * | 1985-08-08 | 1987-09-01 | The United States Of America As Represented By The Department Of Health And Human Services | Adoptive immunotherapy as a treatment modality in humans |
ATE127345T1 (de) * | 1988-06-15 | 1995-09-15 | Whitehead Biomedical Inst | Stressproteine und verwendungen dafür. |
WO1990002564A1 (fr) * | 1988-09-12 | 1990-03-22 | Codon | Vaccin de diagnostic utilisant des proteines homologues a des proteines de thermochoc de trypanosoma cruzi |
US5232833A (en) * | 1988-09-14 | 1993-08-03 | Stressgen Biotechnologies Corporation | Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants |
GB9007194D0 (en) * | 1990-03-30 | 1990-05-30 | Wellcome Found | Live vaccines |
US5348945A (en) * | 1990-04-06 | 1994-09-20 | Wake Forest University | Method of treatment with hsp70 |
US5188964A (en) * | 1990-04-12 | 1993-02-23 | Board Of Regents, The University Of Texas System | Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination |
WO1992008488A1 (fr) * | 1990-11-08 | 1992-05-29 | University College London | Mycobacterium utilise comme adjuvant pour des antigenes |
GB9016315D0 (en) * | 1990-07-25 | 1990-09-12 | Burnie James P | Medicaments |
GB9024320D0 (en) * | 1990-11-08 | 1990-12-19 | Univ London | Treatment of uveitis |
GB2251186A (en) * | 1990-12-04 | 1992-07-01 | Randall Neal Gatz | Polypeptide for use in treatment of autoimmune disease |
WO1993024136A1 (fr) * | 1991-01-17 | 1993-12-09 | Terman David S | Effets tumoricides des enterotoxines, superantigenes et composes apparentes |
GB9200949D0 (en) * | 1992-01-17 | 1992-03-11 | Medical Res Council | Diagnostic peptides |
WO1993018150A1 (fr) * | 1992-03-02 | 1993-09-16 | Biocine S.P.A. | Proteines d'helicobacter pylori utiles pour des vaccins et des diagnostics |
FR2688227A1 (fr) * | 1992-03-04 | 1993-09-10 | Inst Nat Sante Rech Med | Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques. |
IT1262896B (it) * | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
CA2130089A1 (fr) * | 1992-03-09 | 1993-09-16 | Aldo Mancini | Composes proteiques, sequences nucleotidiques codantes, lignee cellulaire productrice et leurs applications |
AU4024593A (en) * | 1992-04-14 | 1993-11-18 | Abbott Laboratories | Method of detecting tumors containing complexes of P53 and HSP70 |
AU4678993A (en) * | 1992-07-16 | 1994-02-14 | Board Of Trustees Of The Leland Stanford Junior University | Methods for using dendritic cells to activate t cells |
IL102687A (en) * | 1992-07-30 | 1997-06-10 | Yeda Res & Dev | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them |
GB2270076A (en) * | 1992-08-18 | 1994-03-02 | Univ Manchester | Human HSP 90 Epitopes |
US6048520A (en) * | 1992-09-24 | 2000-04-11 | Helene Curtis, Inc. | Clear leave-on hair treatment composition and method |
GB9223816D0 (en) * | 1992-11-13 | 1993-01-06 | Medical Res Council | Heat shock proteins and the treatment of tumours |
DK0700445T3 (da) * | 1993-06-04 | 2002-05-13 | Whitehead Biomedical Inst | Stressproteiner og anvendelser deraf |
US5997873A (en) | 1994-01-13 | 1999-12-07 | Mount Sinai School Of Medicine Of The City University Of New York | Method of preparation of heat shock protein 70-peptide complexes |
US5750119A (en) * | 1994-01-13 | 1998-05-12 | Mount Sinai School Of Medicine Of The City University Of New York | Immunotherapeutic stress protein-peptide complexes against cancer |
US5961979A (en) | 1994-03-16 | 1999-10-05 | Mount Sinai School Of Medicine Of The City University Of New York | Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens |
US6663868B1 (en) * | 1995-08-18 | 2003-12-16 | Sloan-Kettering Institute For Cancer Research | Heat shock protein-based vaccines and immunotherapies |
US5837251A (en) * | 1995-09-13 | 1998-11-17 | Fordham University | Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases |
US5985270A (en) | 1995-09-13 | 1999-11-16 | Fordham University | Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes |
US5935576A (en) | 1995-09-13 | 1999-08-10 | Fordham University | Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens |
CA2231998A1 (fr) * | 1995-09-13 | 1997-03-20 | Fordham University | Procedes therapeutique et profilactique utilisant des proteines du choque thermique |
WO1997026910A2 (fr) * | 1996-01-27 | 1997-07-31 | Max-Delbrück-Centrum für Molekulare Medizin | Vaccin antitumoral pour le traitement immunitaire des tumeurs malignes |
DE19602985A1 (de) * | 1996-01-27 | 1997-07-31 | Max Delbrueck Centrum | Tumorzellimpfstoff für die Immuntheraphie von malignen Tumoren |
US5747332A (en) | 1996-09-20 | 1998-05-05 | University Of New Mexico | Methods for purifying and synthesizing heat shock protein complexes |
IN183280B (fr) | 1996-09-20 | 1999-10-30 | Univ New Mexico | |
US5830464A (en) * | 1997-02-07 | 1998-11-03 | Fordham University | Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy |
US6017540A (en) * | 1997-02-07 | 2000-01-25 | Fordham University | Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes |
JP2001525347A (ja) | 1997-12-05 | 2001-12-11 | ザ ユニバーシティ オブ ニュー メキシコ | 熱ショックペプチド錯体の精製方法 |
-
1997
- 1997-02-07 US US08/796,319 patent/US6017540A/en not_active Expired - Lifetime
-
1998
- 1998-02-03 WO PCT/US1998/002193 patent/WO1998034641A1/fr not_active Application Discontinuation
- 1998-02-03 AU AU61455/98A patent/AU724772B2/en not_active Ceased
- 1998-02-03 JP JP53487998A patent/JP2001511785A/ja not_active Ceased
- 1998-02-03 EP EP98906153A patent/EP0973548A4/fr not_active Withdrawn
- 1998-02-03 CA CA002281699A patent/CA2281699A1/fr not_active Abandoned
- 1998-02-06 ZA ZA98978A patent/ZA98978B/xx unknown
-
1999
- 1999-10-26 US US09/427,432 patent/US6447780B1/en not_active Expired - Fee Related
- 1999-11-15 US US09/440,178 patent/US6403095B1/en not_active Expired - Fee Related
- 1999-11-15 US US09/440,173 patent/US6455048B1/en not_active Expired - Fee Related
- 1999-11-15 US US09/439,688 patent/US6383492B1/en not_active Expired - Fee Related
- 1999-11-15 US US09/440,172 patent/US6383494B1/en not_active Expired - Lifetime
- 1999-11-15 US US09/440,179 patent/US6391306B1/en not_active Expired - Fee Related
- 1999-11-15 US US09/439,686 patent/US6436404B1/en not_active Expired - Lifetime
- 1999-11-15 US US09/440,171 patent/US6383493B1/en not_active Expired - Lifetime
- 1999-11-15 US US09/439,684 patent/US6399069B1/en not_active Expired - Fee Related
- 1999-11-15 US US09/439,683 patent/US6379672B1/en not_active Expired - Fee Related
- 1999-11-15 US US09/439,687 patent/US6387374B1/en not_active Expired - Fee Related
- 1999-11-15 US US09/439,685 patent/US6375953B1/en not_active Expired - Lifetime
- 1999-11-15 US US09/440,177 patent/US6399070B1/en not_active Expired - Fee Related
- 1999-11-15 US US09/439,682 patent/US6383491B1/en not_active Expired - Fee Related
-
2002
- 2002-08-02 US US10/212,031 patent/US20030012794A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6017540A (en) | 2000-01-25 |
US6399070B1 (en) | 2002-06-04 |
US6403095B1 (en) | 2002-06-11 |
AU724772B2 (en) | 2000-09-28 |
US6455048B1 (en) | 2002-09-24 |
US6391306B1 (en) | 2002-05-21 |
WO1998034641A1 (fr) | 1998-08-13 |
US6447780B1 (en) | 2002-09-10 |
US6375953B1 (en) | 2002-04-23 |
US6387374B1 (en) | 2002-05-14 |
US6383493B1 (en) | 2002-05-07 |
US6383491B1 (en) | 2002-05-07 |
US6383494B1 (en) | 2002-05-07 |
US20030012794A1 (en) | 2003-01-16 |
CA2281699A1 (fr) | 1998-08-13 |
US6379672B1 (en) | 2002-04-30 |
EP0973548A4 (fr) | 2004-11-10 |
JP2001511785A (ja) | 2001-08-14 |
US6383492B1 (en) | 2002-05-07 |
AU6145598A (en) | 1998-08-26 |
EP0973548A1 (fr) | 2000-01-26 |
US6436404B1 (en) | 2002-08-20 |
US6399069B1 (en) | 2002-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA98978B (en) | Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/ stress protein-peptide complexes | |
IL135029A0 (en) | Prefilled ampoules and manufacture thereof | |
IL112860A0 (en) | Recombinant viruses their preparation and their therapeutic uses | |
IL129352A0 (en) | Benzimidazole-2- carbamates for the treatment of viral infections and cancer | |
IL113867A0 (en) | Aluminum-scandium alloys and uses thereof | |
AU6938298A (en) | Heat shield and method of manufacturing the heat shield | |
DE69515174T2 (de) | Öfen und auskleidungen | |
GB9307287D0 (en) | Improved tabs and manufacture thereof | |
AP9500732A0 (en) | Anti viral and anti cancer agents | |
GB9423267D0 (en) | Compounding elements and use thereof | |
GB9415900D0 (en) | Novel compounds and treatment | |
ZA956382B (en) | Novel n-benzylindole and benzopyrazole derivatives with anti-asthmatic anti-allergic anti-inflammatory and immune modulating effect | |
GB9503886D0 (en) | Refractory mix and shapes made therefrom | |
IL115853A0 (en) | Aryloxycycloalkenyl and aryloxyiminocyclo-alkenylhydroxyureas | |
GB9517670D0 (en) | Furnaces | |
GB2292878B (en) | Footwear and the manufacture thereof | |
HU9400634D0 (en) | Vaccine and diagnosticum against parvovirosis of gooses and barbari duks | |
GB2289790B (en) | Planar lamps and displays | |
GB9720167D0 (en) | Nums and Sums | |
LTIP2063A (en) | Dessert-cheese and manufacture thereof | |
GB9410969D0 (en) | Hemorrhoid treatment and prevention | |
AU124232S (en) | Heating lamp and fan fitting | |
AU124233S (en) | Heating lamp and fan fitting | |
GB9209549D0 (en) | Nolan podger | |
IL125145A0 (en) | Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |